IGF DES 1 Mg Beligas Pharma USA

IGF-1 DES 1 mg Vial (Beligas Pharma) – Potent Muscle-Building Peptides

Product Description:
IGF-1 DES by Beligas Pharma is a synthetic variant of Insulin-like Growth Factor-1 (IGF-1), engineered for enhanced muscle-building and recovery properties. Each pack contains 1 vial x 1 mg + bacteriostatic water for reconstitution.

Unlike standard IGF-1, the DES version has a shorter half-life and greater binding affinity, making it ideal for localized muscle growth and targeted recovery. Bodybuilders use it to accelerate muscle hyperplasia, fat loss, and connective tissue repair.

Key Features

• Manufacturer: Beligas Pharma

• Active Ingredient: IGF-1 DES

• Strength: 1 mg per vial

• Pack Size: 1 vial + bacteriostatic water

• Form: Injectable peptide

• Category: Growth factor peptide

• Purity: Third-party lab-tested for potency and safety

How IGF-1 DES Works

• Stimulates muscle hyperplasia (new muscle fiber growth)

• Enhances protein synthesis and nutrient uptake

• Improves collagen synthesis, aiding joint and tendon repair

• Supports fat metabolism and nutrient partitioning

• Works synergistically with HGH and testosterone for maximum results

Uses & Benefits of IGF-1 DES

• Rapid muscle growth via new fiber development

• Accelerated recovery and reduced DOMS (delayed-onset muscle soreness)

• Fat loss support through improved nutrient utilization

• Joint and tendon repair for long-term training longevity

• Localized injections enhance growth at specific target sites

Dosage & Administration

• Typical Dosage: 50–100 mcg daily

• Injection Method: Subcutaneous or intramuscular (localized for targeted growth)

• Cycle Duration: 4–6 weeks

• Best Stacks With: Human Growth Hormone (HGH) or testosterone-based cycles

Possible Side Effects of IGF-1 DES

When used responsibly, IGF-1 DES is generally safe, but potential effects include:

• Hypoglycemia (low blood sugar) if misused

• Temporary water retention

• Risk of organ enlargement with prolonged high-dose abuse

Who Should Avoid IGF-1 DES?

• Individuals with active cancers (due to growth factor stimulation)

• Diabetics (unless under strict medical supervision)

• Adolescents or users under 21 years old